Price Alert

MindWalk Corp. (HYFT)

NASDAQ: HYFT · Real-Time Price · USD

1.77

-0.12 (-6.35%)

At close: Sep 25, 2025, 3:59 PM

1.81

2.26%

After-hours: Sep 25, 2025, 05:19 PM EDT

-6.35% (1D)

Bid	1.69
Market Cap	81.7M
Revenue (ttm)	24.52M
Net Income (ttm)	-30.23M
EPS (ttm)	-0.61
PE Ratio (ttm)	-2.9
Forward PE	-9.1
Analyst	n/a
Dividends	n/a

Ask	1.85
Volume	735,145
Avg. Volume (20D)	1,884,212
Open	1.90
Previous Close	1.89
Day's Range	1.75 - 1.94
52-Week Range	0.27 - 3.25
Beta	0.49
Ex-Dividend Date	n/a

About HYFT

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol HYFT

Website n/a

Full Company Profile

Earnings Surprise

MindWalk has released their quartely earnings on Sep 15, 2025:

Revenue of $2.3M misses estimates by $1.83M, with 27.83% YoY growth.

EPS of -0.07 misses estimates by -0.03, with 41.67% YoY growth.

Next Earnings Release

MindWalk Corp. is scheduled to release its earnings on Dec 9, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 days ago

+16.18%

MindWalk shares are trading higher after the compa... Unlock content with Pro Subscription

1 week ago

-20.36%

MindWalk Holdings shares are trading lower after the company reported worse-than-expected Q1 financial results.

News

3 days ago · businesswire.com

MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #AI--MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), a Bio-Native AI company, today announced a major advancement of its AI-desi...

3 weeks ago · businesswire.com

ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”

AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announ...

1 month ago · businesswire.com

ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation

AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a biotherapeutics company delivering advanced solutions in biologics and drug discove...

1 month ago · businesswire.com

AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities With Acquisition of ImmunoPrecise Antibodies Europe From ImmunoPrecise Antibodies Ltd.

WASHINGTON & NORWICH, Conn.--(BUSINESS WIRE)--Arlington Capital Partners (“Arlington”), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced...

1 month ago · fool.com

ImmunoPrecise (IPA) Q4 2025 Earnings Transcript

Image source: The Motley Fool.

1 month ago · seekingalpha.com

ImmunoPrecise Antibodies Ltd. (IPA) Q4 2025 Earnings Conference Call Transcript

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q4 2025 Earnings Call July 29, 2025 10:30 AM ET Company Participants Jennifer Lynne Bath - CEO, President & Non-Independent Director Joseph Scheffler - Inte...

1 month ago · zacks.com

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates

ImmunoPrecise Antibodies Ltd. (IPA) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.02.

1 month ago · businesswire.com

ImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDA

AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (“IPA”, “Company”, “we” or “us”) (NASDAQ: IPA), a bio-native AI company operating at the intersection of TechBio and next-gen...

2 months ago · businesswire.com

ImmunoPrecise Releases New Findings Showing LENSai™ Quickly Flags Anti-Drug-Antibody Risk—Long Before the Clinic

AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a Bio-Native AI pioneer operating where TechBio meets true biological intelligence, t...

2 months ago · businesswire.com

ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board

AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation ...

Load More News